US2022280496A1PendingUtilityA1

Processes of making and crystalline forms of a mdm2 inhibitor

75
Assignee: AMGEN INCPriority: Jun 10, 2013Filed: Oct 13, 2021Published: Sep 8, 2022
Est. expiryJun 10, 2033(~6.9 yrs left)· nominal 20-yr term from priority
C07B 2200/13A61P 35/00A61K 31/45C07C 309/25C07D 491/048C07D 211/76C07D 498/04C07C 309/35C07C 309/04C07C 313/02A61K 31/451C07D 211/94A61P 43/00A61P 35/02
75
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides processes for making 2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid as well as intermediates and processes for making the intermediates. Also provided are crystalline forms of the compound and the intermediates.

Claims

exact text as granted — not AI-modified
1 - 12 . (canceled) 
     
     
         13 . A process for making 
       
         
           
           
               
               
           
         
         the process comprising: reacting 
       
       
         
           
           
               
               
           
         
         under dehydrating conditions with 
       
       
         
           
           
               
               
           
         
         to form 
       
       
         
           
           
               
               
           
         
       
     
     
         14 . The process of  claim 14 , wherein the dehydrating conditions are azeotropic distillation with toluene. 
     
     
         15 . A process of making 
       
         
           
           
               
               
           
         
         the process comprising: reacting 
       
       
         
           
           
               
               
           
         
         with 
       
       
         
           
           
               
               
           
         
         to form 
       
       
         
           
           
               
               
           
         
         wherein X is CF 3 SO 3   − or 
       
       
         
           
           
               
               
           
         
       
     
     
         16 . (canceled) 
     
     
         17 . (canceled) 
     
     
         18 . A process of making 
       
         
           
           
               
               
           
         
         the process comprising reacting 
       
       
         
           
           
               
               
           
         
         in presence of a base, to form 
       
       
         
           
           
               
               
           
         
         oxidizing 
       
       
         
           
           
               
               
           
         
         to form 
       
       
         
           
           
               
               
           
         
         which is further converted to 
       
       
         
           
           
               
               
           
         
       
     
     
         19 .- 38 . (canceled) 
     
     
         39 . The process of  claim 18 , wherein the base is sodium tert-butoxide.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.